3 Broker Favorite Biopharmas Your Portfolio Must Have Post author:Sam Post published:January 17, 2018 Post category:BioPharma These stocks have been given a Strong Buy or Buy rating by 80% or more brokers. Source: BioSpace You Might Also Like Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017 TG Therapeutics Announces Follow-Up Data From The Chemo-Free Triple Combination Of TG-1101, TGR-1202, And Ibrutinib At The 53rd Annual Meeting Of The ASCO June 4, 2017 Regeneron to Terminate Its Antibody Discovery Pact With Sanofi August 2, 2017
Baxter International To Host First Quarter 2017 Financial Results Conference Call For Investors March 22, 2017
TG Therapeutics Announces Follow-Up Data From The Chemo-Free Triple Combination Of TG-1101, TGR-1202, And Ibrutinib At The 53rd Annual Meeting Of The ASCO June 4, 2017
